PH31220A - Medical treatment. - Google Patents

Medical treatment.

Info

Publication number
PH31220A
PH31220A PH49876A PH49876A PH31220A PH 31220 A PH31220 A PH 31220A PH 49876 A PH49876 A PH 49876A PH 49876 A PH49876 A PH 49876A PH 31220 A PH31220 A PH 31220A
Authority
PH
Philippines
Prior art keywords
medical treatment
monohydrate
cyclobutyl
chlorophenyl
humans
Prior art date
Application number
PH49876A
Other languages
English (en)
Inventor
Vargas Ramon
Original Assignee
Boots Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH31220(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boots Pharma Inc filed Critical Boots Pharma Inc
Publication of PH31220A publication Critical patent/PH31220A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubricants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PH49876A 1994-02-03 1995-02-01 Medical treatment. PH31220A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/190,924 US5459164A (en) 1994-02-03 1994-02-03 Medical treatment

Publications (1)

Publication Number Publication Date
PH31220A true PH31220A (en) 1998-05-05

Family

ID=22703362

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49876A PH31220A (en) 1994-02-03 1995-02-01 Medical treatment.

Country Status (17)

Country Link
US (2) US5459164A (enExample)
EP (1) EP0814788B1 (enExample)
JP (1) JPH10503166A (enExample)
KR (1) KR100339874B1 (enExample)
CN (1) CN1070698C (enExample)
AT (1) ATE205390T1 (enExample)
AU (1) AU694761B2 (enExample)
CA (1) CA2182620C (enExample)
DE (1) DE69522716T2 (enExample)
DK (1) DK0814788T3 (enExample)
ES (1) ES2166817T3 (enExample)
IL (1) IL112515A (enExample)
PH (1) PH31220A (enExample)
PT (1) PT814788E (enExample)
TW (1) TW314466B (enExample)
WO (1) WO1995020949A1 (enExample)
ZA (1) ZA95814B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9619961D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
BG65170B1 (bg) * 1999-03-17 2007-05-31 Knoll Gmbh Използване на n-заместени производни на 1-[1-(4-хлорофенил)циклобутил]-3-метилбутиламин за производство на лекарство за лечение на разстройства при храненето
US6372798B1 (en) 1999-03-19 2002-04-16 Knoll Pharmaceutical Company Treatment of hyperactivity disorders
TR200102699T2 (tr) * 1999-03-19 2002-03-21 Knoll Gmbh Kronik mafsal bozukluĞunun (osteoarthritis) tedavisi
KR20010113765A (ko) * 1999-03-19 2001-12-28 독터. 호르스트 하스칼, 잉에 린스 체중 증가와 관련된 특정 암의 치료방법
US6803387B1 (en) 1999-03-19 2004-10-12 Abbott Gmbh & Co. Kg Treatment of neuropathic pain or fibromyalgia
AU3895300A (en) * 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of chronic fatigue syndrome
BR0009159A (pt) * 1999-03-19 2001-12-26 Knoll Gmbh Método de controle do ganho de peso associadocom drogas terapêuticas
AU3760900A (en) * 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of menstrual function
AU3894500A (en) * 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Prevention of cardiovascular disease
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6403650B1 (en) * 1999-03-19 2002-06-11 Knoll Pharmaceutical Company Treatment of pulmonary hypertension
CA2367022A1 (en) * 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Method of treating sleep apnoea
US6365632B1 (en) 1999-03-19 2002-04-02 Knoll Pharmaceuticals Company Treatment of orthostatic hypotension
EP1165060A4 (en) * 1999-03-19 2002-06-12 Knoll Gmbh PROCESSING OF BILARIAL CALCULATIONS
US6441046B1 (en) 1999-03-19 2002-08-27 Abbott Gmbh & Co. Kg Control of metabolism
WO2000056315A1 (en) * 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Treatment of pain
AU3894600A (en) * 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Method of treating sexual dysfunction
GB9914744D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
GB9926251D0 (en) * 1999-11-06 2000-01-12 Knoll Ag Pharmaceutical formulation
US6232347B1 (en) 2000-03-17 2001-05-15 Knoll Pharmaceutical Company Treatment of osteoarthritis
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US20040034101A1 (en) * 2001-11-05 2004-02-19 Cypress Bioscience, Inc. Treatment and prevention of depression secondary to pain (DSP)
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
HRP20050307A2 (en) * 2002-10-05 2006-12-31 Hanmi Pharm. Co. Ltd. Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
JP2008526836A (ja) 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション シブトラミンの無機酸塩
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
EP0294028B1 (en) * 1987-05-04 1993-09-01 Eli Lilly And Company Fluoxetine useful for the treatment of diabetes
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity

Also Published As

Publication number Publication date
ES2166817T3 (es) 2002-05-01
CN1144479A (zh) 1997-03-05
DE69522716D1 (de) 2001-10-18
DK0814788T3 (da) 2001-11-19
TW314466B (enExample) 1997-09-01
EP0814788A4 (en) 1999-05-06
CN1070698C (zh) 2001-09-12
AU1736295A (en) 1995-08-21
WO1995020949A1 (en) 1995-08-10
IL112515A0 (en) 1995-12-08
KR100339874B1 (ko) 2002-11-22
EP0814788B1 (en) 2001-09-12
PT814788E (pt) 2002-03-28
ZA95814B (en) 1995-08-03
US5942549A (en) 1999-08-24
IL112515A (en) 2000-07-26
US5459164A (en) 1995-10-17
EP0814788A1 (en) 1998-01-07
AU694761B2 (en) 1998-07-30
JPH10503166A (ja) 1998-03-24
DE69522716T2 (de) 2002-05-29
CA2182620A1 (en) 1995-08-10
ATE205390T1 (de) 2001-09-15
CA2182620C (en) 2007-01-16

Similar Documents

Publication Publication Date Title
ZA95814B (en) Medical treatment
BG103277A (en) Application of sibutramine analogues for the prevention of diabetes development
EG17770A (en) A process for the preparation of therapeutic compound which is useful in the treatment of depression
IL128820A0 (en) Medical treatment
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
BG103278A (en) Medicamentous treatment
WO2000056315A8 (en) Treatment of pain
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
CA2248794A1 (en) Medicament for preventive and treatment for viral infectious diseases
MXPA01009461A (es) Tratamiento de osteoartritis.
HK1045254A1 (zh) 降低血小板黏性的处理方法
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
WO2000056316A8 (en) Treatment of gallstones
MXPA01009463A (es) Tratamiento de hernia hiatial.
MXPA01009465A (es) Perdida de peso despues del embarazo.
TH52365A (th) การรักษาทางการแพทย์
RU99108729A (ru) Способ лечения